JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 35 No. 10 1659-1661
© 1994 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seto, H.
Right arrow Articles by Kakishita, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seto, H.
Right arrow Articles by Kakishita, M.

Assessment of Residual Tumor Viability in Thymic Carcinoma by Sequential Thallium-201 SPECT: Comparison with CT and Biopsy Findings

Hikaru Seto, Masanari Kageyama, Masashi Shimizu, Yi-wei Wu, Tetsuya Kamei and Masao Kakishita

Department of Radiology, Toyama Medical and Pharmaceutical University, Toyama City, Toyama, Japan

Correspondence: For correspondence or reprints contact: Hikaru Seto, MD, Department of Radiology, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama City, Toyama, 930-01, Japan.

ABSTRACT

We present a case of 201Tl accumulating thymic carcinoma, in which sequential CT scans demonstrated a steady decrease in tumor volume. The presence of a residual mass on CT scans after the completion of therapy presented the clinical dilemma of whether or not a viable tumor remained. Sequential 201Tl SPECT images demonstrated a marked decrease in tumor uptake. At 2 wk after therapy, no significant accumulation of 201Tl in the region of the residual mass was observed, indicating a lack of viable tumor. A biopsy specimen revealed no tumor cells. Sequential histopathologic findings were correlated well with the findings of 201Tl SPECT rather than those of CT. Thallium-201 SPECT is of great clinical value in assessing tumor viability in the course of therapy.

Key Words: thallium-201 • SPECT • viability • thymic carcinoma • computed tomography




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
T. Iwata, K. Inoue, S. Mizuguchi, R. Morita, T. Tsukioka, and S. Suehiro
Thymic Small Cell Carcinoma Associated With Pulmonary Squamous Cell Carcinoma
Ann. Thorac. Surg., December 1, 2006; 82(6): 2266 - 2268.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1994 by the Society of Nuclear Medicine.